Kenvue Plunges 13%: From Baby Powder Lawsuits to Tylenol Scares
Kenvue's stock fell 13% due to thousands of lawsuits over baby powder in the UK and a potential review linking Tylenol to autism. The consumer-health company is facing increased instability with multiple lawsuits, an interim CEO, layoffs, and activist investor interest.